Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Sponsor: Vor Biopharma
Chicago, IL · Schaumburg, IL · Willowbrook, IL · +44 more sites
11 recruiting rheumatoid arthritis studies with a site in Chicago, IL.
Sponsor: Vor Biopharma
Chicago, IL · Schaumburg, IL · Willowbrook, IL · +44 more sites
Sponsor: Novartis Pharmaceuticals
Chicago, IL · Willowbrook, IL · +7 more sites
Sponsor: AbbVie
Chicago, IL · Libertyville, IL · Orland Park, IL · +46 more sites
Sponsor: National Cancer Institute (NCI)
Chicago, IL · +49 more sites
Sponsor: Duke University
Chicago, IL · +72 more sites
Sponsor: Nkarta, Inc.
Chicago, IL · +15 more sites
Sponsor: AstraZeneca
Chicago, IL · +7 more sites
Sponsor: Sonoma Biotherapeutics, Inc.
Chicago, IL · +8 more sites
Sponsor: Sonoma Biotherapeutics, Inc.
Chicago, IL · +9 more sites
Sponsor: Children's Hospital of Philadelphia
Chicago, IL · +22 more sites
Sponsor: Northwestern University
Chicago, IL
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.